Fondation de l'Hopital Maisonneuve-Rosemont
STAR RATINGCi's Star Rating is calculated based on the following independent metrics: |
✔
FINANCIAL TRANSPARENCY
Most recent Audited financial statements available on the charity’s website.
C+
RESULTS REPORTING
Grade based on the charity's public reporting of the work it does and the results it achieves.
n/r
DEMONSTRATED IMPACT
The demonstrated impact per dollar Ci calculates from available program information.
NEED FOR FUNDING
Charity's cash and investments (funding reserves) relative to how much it spends on programs in most recent year.
63%
CENTS TO THE CAUSE
For a dollar donated, after overhead costs of fundraising and admin/management (excluding surplus) 63 cents are available for programs.
My anchor
OVERVIEW
About Fondation de l'Hopital Maisonneuve-Rosemont:
Founded in 1978, Fondation de l’Hopital Maisonneuve-Rosemont (FHMR) raises funds for patient care, research and equipment at Hopital Maisonneuve-Rosemont, the largest hospital centre in Eastern Montreal. The hospital specializes in the fields of ophthalmology (study of eye diseases), immunology-oncology (cancer treatment) and nephrology (study of kidney diseases). Hopital Maisonneuve-Rosemont serves 26% of Montreal’s population.
In F2019, Fondation de l’Hopital Maisonneuve-Rosemont allocated $12.1m to the hospital. 66% of grants went to fund research, 31% was used to purchase equipment, and 3% was devoted to teaching. The foundation funded 59 projects in F2019.
In F2018, the foundation invested $130,000 in a respirator and physiological monitor. The foundation also invested $95,100 in an eye scanner to help shorten patient wait times. In terms of research, Fondation de l’Hopital Maisonneuve-Rosemont granted $63,000 to a research team that is working on a new medication to eliminate damaged cells in the eye. In 2016, the foundation helped the hospital create the Multidisciplinary Centre of Excellence, which supports the knowledge transfer between students and professionals. In F2018, the foundation invested $10,000 into the centre to support the creation of a virtual test library to support the teaching of interns.
Specific data on program outputs could not be found in the foundation’s 2019 Annual Report.
My anchor
Results and Impact
Since October 2019, Hopital Maisonneuve-Rosemont, under the direction of Dr. Isabelle Fleury, has developed a new treatment option for patients with blood cancer. The treatment uses CAR-T cell therapy, which modifies specific cells and enables them to destroy the cancer. Currently, the treatment is only available to certain groups of patients who do not respond to traditional therapies. Over the years, Fondation de l’Hopital Maisonneuve-Rosemont has provided the research team with more than $100,000 to develop the CART-T cell treatment.
While Charity Intelligence highlights these key results, they may not be a complete representation of Fondation de l’Hopital Maisonneuve-Rosemont's results.
My anchor
Finances
Fondation de l’Hopital Maisonneuve-Rosemont is a Major 100 charity, meaning it is one of Canada’s largest charities in terms of donations. The foundation received $22.5 million in donations in F2019. The charity also received $11.5m in investment income.
Administrative costs are 11% of revenues and fundraising costs are 26% of donations. For every dollar donated, 63 cents go the cause. This is not within Ci’s reasonable range for overhead spending. The charity holds $103.7m in funding reserves, of which $47.9m is donor-endowed. Excluding donor-endowed funds, Fondation de l’Hopital Maisonneuve-Rosemont can cover 5.7 years of annual program costs.
The charity spent $484k on capital expenditures in F2019, $3.8m in F2018, and $3.6m in F2017. The majority of capital expenditures relate to hospital building construction.
This charity report is an update that has been sent to Fondation de l’Hopital Maisonneuve-Rosemont for review. Changes and edits may be forthcoming.
Updated on July 3, 2020 by Tenzin Shomar.
Financial Review
Fiscal year ending December
|
2019 | 2018 | 2017 |
|---|---|---|---|
| Administrative costs as % of revenues | 11.1% | 9.5% | 10.1% |
| Fundraising costs as % of donations | 26.1% | 24.0% | 26.0% |
| Total overhead spending | 37.2% | 33.5% | 36.1% |
| Program cost coverage (%) | 573.7% | 567.3% | 535.0% |
Summary Financial StatementsAll figures in $000s |
2019 | 2018 | 2017 |
|---|---|---|---|
| Donations | 22,538 | 23,443 | 21,794 |
| Investment income | 11,453 | (1,084) | 7,363 |
| Total revenues | 33,991 | 22,359 | 29,158 |
| Grants | 12,126 | 11,097 | 9,453 |
| Administrative costs | 2,505 | 2,234 | 2,208 |
| Fundraising costs | 5,885 | 5,625 | 5,663 |
| Total spending | 20,515 | 18,955 | 17,323 |
| Cash flow from operations | 13,476 | 3,404 | 11,834 |
| Capital spending | 484 | 3,792 | 3,618 |
| Funding reserves | 103,734 | 92,421 | 80,679 |
Note: Charity Intelligence has analyzed the charity’s French audited financial statements to the best of our abilities but recognizes that detailed financial information is beyond our linguistic expertise. Material omissions may be reflected in Charity Intelligence’s analysis. Ci included change in fair value of investments in its revenues calculation, decreasing revenues by $2.3m in F2017.
Salary Information
$350k + |
0 |
$300k - $350k |
0 |
$250k - $300k |
0 |
$200k - $250k |
0 |
$160k - $200k |
0 |
$120k - $160k |
1 |
$80k - $120k |
4 |
$40k - $80k |
5 |
< $40k |
0 |
Information from most recent CRA Charities Directorate filings for F2019
My anchor
Comments & Contact
Comments added by the Charity:
Charity Contact
This email address is being protected from spambots. You need JavaScript enabled to view it. Tel: 514-252-3435